Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.21.69 (
APC
)
16,337
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Surfactant
protein C
(SP-C) is synthesized by type II pneumocytes as a 21-kD propeptide (proSP-C) which is proteolytically processed to a 4.2-kD dipalmitoylated protein. To characterize the processing of proSP-C and the role of the cysteine protease
cathepsin H
, we studied the localization of proSP-C and
cathepsin H
in human as well as proSP-C in rat lungs, the enzymatic
cathepsin H
activity in isolated rat lamellar bodies, and the cleavage of human proSP-C by purified
cathepsin H
. Using antisera directed against the N-terminal E(11)-R(23) (NPROSP-C(11-23)), the C-terminal G(162)-G(174) domain (CPROSP-C(162-174)) of proSP-C, and against
cathepsin H
, immunogold labeling identified all three in electron-dense multivesicular bodies, but only NPROSP-C(11-23) and
cathepsin H
in composite as well as lamellar bodies of type II pneumocytes. Immuno double-labeling further distinguished electron-dense vesicles containing
cathepsin H
or electron light vesicles/multivesicular bodies containing proSP-C. Isolated lamellar bodies contained enzymatically active
cathepsin H
, a 6-kD proSP-C processing intermediate detected only by NPROSP-C(11-23), and mature SP-C. Using enzyme activities comparable to those in isolated lamellar bodies, purified
cathepsin H
generated a partially N-terminal processed proSP-C intermediate in vitro. In conclusion, our results indicate that after the fusion of electron-dense vesicles containing
cathepsin H
and electron-light vesicles or multivesicular bodies containing proSP-C,
cathepsin H
is involved in the first N-terminal processing step of proSP-C in electron-dense multivesicular bodies of type II pneumocytes.
...
PMID:Involvement of cathepsin H in the processing of the hydrophobic surfactant-associated protein C in type II pneumocytes. 1203 64